Cerner Enviza

Oracle has been a leader in life sciences for more than 40 years, igniting innovation through powerful and connected research, data, and technology. We deliver consultative end-to-end solutions and guidance throughout the therapeutic development lifecycle. Whether supporting the management of clinical trials and pharmacovigilance with market-leading tools, generating real-world evidence from unique data sets or guiding brand strategy with commercial insights, Oracle Life Sciences empowers the life sciences industry in its mission to improve patient outcomes. Learn more at oracle.com/life-sciences

On December 20, 2021, Oracle and Cerner jointly announced an agreement for Oracle to acquire Cerner through an all-cash tender offer for $95.00 per share, or approximately $28.3 billion in equity value. Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better healthcare to individual patients and communities.